A phase III , multicentre, randomised, investigator-masked, cross-over, comparative efficacy study of a generic Brinzolamide 10 mg/ml ophthalmic suspension (Azad Pharma AG) and Brinzolamide 10 mg/ml ophthalmic suspendion (Azopt�, Alcon) in open-angle glau
Read time: 1 mins
Last updated:10th Jan 2012
The primary objective of this study is to evaluate the efficacy of Brinzolamide 10 mg/ml ophthalmic suspension (Azad Pharma AG) in lowering intraocular pressure (IOP) when compared to Azopt� ophthalmic suspension ( Brinzolamide Alcon,).
|Study start date||2012-01-10|